LHLijin Huang

Lijin Huang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lijin Huang has a total of 24 co-authors. Here are the top co-authors by number of shared publications:

  • Xu Lu

    Department of Pharmacognosy, State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 210009, China

    3 shared publications
  • Dian Jin

    State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy China Pharmaceutical University Nanjing 211198 China

    2 shared publications
  • Jinfa Du

    Clinical Metabolomics Center, School of Traditional Chinese Pharmacy China Pharmaceutical University Nanjing 211198 China

    2 shared publications
  • Xinyue Xing

    State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy China Pharmaceutical University Nanjing 211198 China

    2 shared publications
  • Henrik Vibe Scheller

    Joint BioEnergy Institute , Emeryville, CA 94608

    1 shared publication
  • Huijun Guo

    Department of Pharmacognosy, State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University

    1 shared publication

Latest Publications

  • Time‐delayed activator–repressor regulation of ginsenoside biosynthesis in Gynostemma pentaphyllum

    by Lijin Huang, Jinfa Du, Yuhong Chen, Dian Jin, Yuyin Zhao, Xinyue Xing, Long Wang, Yingping Wang, Peina Zhou, Yucheng Zhao, et al.

    Summary: Jasmonic acid (JA) signaling is a key regulator of plant secondary metabolism, yet how it balances rapid activation with timely repression of ginsenoside biosynthesis remains unclear in Gynostemma pentaphyllum . Here, we investigated the transcriptional regulation mechanism of ginsenoside biosynthesis by JA–responsive basic helix–loop–helix (bHLH) transcription factors. By integrating transcriptome and phylogenetic analyses with yeast one‐hybrid, electrophoretic mobility shift assays, dual‐luciferase assays, transgenic hairy root overexpression, and RNA interference, together with metabolite profiling, we identified key regulators and defined their roles in the ginsenoside biosynthesis pathway of G. pentaphyllum . We characterized an antagonistic bHLH pair, GpGAB (g36559, Activator), and GpGIB (g21771, Inhibitor). GpGAB activated ginsenoside biosynthetic genes GpDS , GpPPDS , and GpUGT94AT1 , whereas GpGIB repressed the expression of GpDS and GpPPDS . GpGAB also upregulated the expression of GpGIB , with GpGAB responding earlier than GpGIB to JA treatment. Taken together, our results support a model in which GpGAB and GpGIB form a time‐delayed negative feedback loop that fine‐tunes ginsenoside biosynthesis after JA induction, providing a mechanistic framework for dynamic transcriptional regulation of ginsenoside in G. pentaphyllum .


  • Open Access

    Identification of a central regulator of ginkgolide biosynthesis in Ginkgo biloba that integrates jasmonate and light signaling

    by Jinfa Du, Zhen Zhao, Lingqi Jin, Lijin Huang, Dian Jin, Xiaoyan Zheng, Qiaolei Wang, Wenbo Xu, Huijun Guo, Xinyue Xing, et al.

    Ginkgolides are secondary metabolites unique to Ginkgo biloba with the potential to prevent and treat cardiovascular and cerebrovascular diseases. Although the biosynthetic pathways of ginkgolides have been partly uncovered, the mechanism regulating their biosynthesis is still largely unknown. Here, using multiomic and genetic analyses, we report the identification of a transcription factor, named ETHYLENE RESPONSE FACTOR ASSOCIATED WITH GINKGOLIDE BIOSYNTHESIS (GbEAG), as a critical regulator of ginkgolide biosynthesis. GbEAG is highly expressed in the roots of G. biloba, and its expression is significantly induced by methyl jasmonate (MeJA). Ginkgolide content was significantly increased in roots by overexpressing GbEAG using a “cut-dip-regeneration” system. GbEAG positively regulates ginkgolide biosynthesis by directly binding to the GCC-boxes in the promoter regions of genes involved in the biosynthesis of ginkgolides, such as ISOPENTENYL DIPHOSPHATE ISOMERASE ( GbIDI ) and CYTOCHROME P450 7005C3 ( GbCYP7005C3 ). GbEAG mediates the jasmonic acid (JA)-activated ginkgolide synthesis through its direct interaction with the JASMONATE ZINC-FINGER INFLORESCENCE MERISTEM DOMAIN 3 (GbJAZ3) repressor. Importantly, we also found that the central light-response regulator ELONGATED HYPOCOTYL 5 (GbHY5) mediates light induction of ginkgolide biosynthesis by binding to the G-box in the GbEAG promoter. Our findings provide mechanistic insights into the coordinated regulation of ginkgolide biosynthesis via JA and light signals, with GbEAG as a central regulator in G. biloba, and shed light on the potential to develop ginkgolide-rich varieties through molecular breeding and gene editing.


  • Medicinal terpenoid UDP-glycosyltransferases in plants: recent advances and research strategies

    by Xu Lu, Lijin Huang, Henrik V Scheller, Jay D Keasling

    Terpenoid glycosides have significant curative effects on many kinds of diseases. Most of these compounds are derived from medicinal plants. Glycosylation is a key step in the biosynthesis of medicinal terpenoids. In plants, UDP-dependent glycosyltransferases comprise a large family of enzymes that catalyze the transfer of sugars from donor to acceptor to form various bioactive glycosides. In recent years, numerous terpenoid UDP-glycosyltransferases (UGTs) have been cloned and characterized in medicinal plants. We review the typical characteristics and evolution of terpenoid-related UGTs in plants and summarize the advances and research strategies of terpenoid UGTs in medicinal plants over the past 20 years. We provide a reference for the study of glycosylation of terpenoid skeletons and the biosynthetic pathways for medicinal terpenoids in plants.